Eton Pharmaceutcials, Inc. Common Stock (ETON) is a publicly traded Healthcare sector company. As of May 20, 2026, ETON trades at $33.86 with a market cap of $889.98M and a P/E ratio of -651.88. ETON moved +1.12% today. Year to date, ETON is +102.28%; over the trailing twelve months it is +68.06%. Its 52-week range spans $5.40 to $33.41. Analyst consensus is strong buy with an average price target of $45.67. Rallies surfaces ETON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes ETON SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $33.86 |
| Market Cap | $889.98M |
| P/E Ratio | -651.88 |
| EPS | $-0.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.41 |
| 52-Week Low | $5.40 |
| Volume | 414.81K |
| Avg Volume | 0 |
| Revenue (TTM) | $86.93M |
| Net Income | $-1.48M |
| Gross Margin | 54.77% |
3 analysts cover ETON: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.67.